News from Aotearoa/New Zealand and the Pacific Islands

MECFS Canterbury and M.E. Awareness NZ approached both Emeritus Prof Warren Tate, University of Otago, and Dr Lynette Hodges, Massey University, about making a statement about the suitability of exercise treatment protocols for people with ME.

These statements have been published on https://m.e.awareness.nz/statements-from-academics

It is hoped that these statements will assist health professionals, insurers and others, to get up-to-date with current research findings about ME/CFS and appropriate management of the illness.
 
MECFS Canterbury and M.E. Awareness NZ approached both Emeritus Prof Warren Tate, University of Otago, and Dr Lynette Hodges, Massey University, about making a statement about the suitability of exercise treatment protocols for people with ME.

These statements have been published on https://m.e.awareness.nz/statements-from-academics

It is hoped that these statements will assist health professionals, insurers and others, to get up-to-date with current research findings about ME/CFS and appropriate management of the illness.
Thanks. I found the discussion of the exercise intensity of specific activities of work and daily activities towards the end of Dr Hodges’ statement interesting.
 
This showed up in a search because of reference 6. Unfortunately, I can't access it, so I have no idea how worthwhile it is to highlight.

https://www.nzdoctor.co.nz/node/19379

What to expect the first time you encounter a patient with ‘long COVID’
1 September 2021

References
1. Ministry of Health. COVID-19: Current cases. 17 August 2021. https://www.health.govt.nz/our-work...19-data-and-statistics/covid-19-current-cases

2. Liu B, Jayasundara D, Pye V, et al. Whole of population-based cohort study of recovery time from COVID-19 in New South Wales Australia. Lancet Reg Health West Pac 2021;12:100193.

3. Davis HE, Assaf GS, McCorkell L, et al. Characterizing long COVID in an international cohort: 7 months of symptoms and their impact. EClinicalMedicine 2021;101019: 15 July online.

4. Centers for Disease Control and Prevention. Post-COVID Conditions. 12 July 2021. https://www.cdc.gov/coronavirus/2019-ncov/long-term-effects.html

5. Editorial. COVID-19 pathophysiology: looking beyond acute disease. Lancet Respir Med 2021;9(6):545.

6. Campbell Murdoch. Can ‘Long COVID’ shine light on Chronic Fatigue Syndrome? 7 December 2020. https://www.nzdoctor.co.nz/article/opinion/can-long-covid-shine-light-chronic-fatigue-syndrome

7. National Health Service. NHS sets up specialist young people’s services in £100 million long COVID care expansion. 15 June 2021. https://www.england.nhs.uk/2021/06/...ces-in-100-million-long-covid-care-expansion/

8. Nalbandian A, Sehgal K, Gupta A, et al. Post-acute COVID-19 syndrome. Nat Med 2021;27(4):601–15.
 
Kia ora koutou, I've just had a conversation with a PwME from Christchurch, who has recently been referred to a psychiatrist as part of the requirements for receiving income protection insurance payments.

The psychiatrist diagnosed him with somatic symptom disorder :(. His insurance claim has thus been refused :(.

I think the only way to overturn this (other than through a positive disease diagnosis) would be by getting a second psychiatric opinion. S I was wondering if anyone here knew of an ME-friendly psychiatrist?

I think its unclear whether this person actually meets the DSM-5 criteria for SSD, because they require excessive anxiety and concern about the health issue. So there's a chance tof challenging the diagnosis.

To be honest, I'm not even sure ME-friendly psychiatrists exist. But here's hoping...

PS feel free to pm me if you prefer.
 
So sorry to hear this. I have concerns that I would have the same fate, so I haven't tried to invoke insurance so far (still hoping to slowly get myself out of this nightmare, with excellent support from my employer).

It seems a long shot that there even might be an ME-friendly psychiatrist. I might be prejudiced by all I've learned over the last few months, but evidence to date suggests that psychiatric training is likely to be dogmatic in the extreme.

Edit: typo
 
Last edited:
Very sad to hear about that situation.

N=1 again, but I have a friend in NZ who has actually found a psych (psychiatrist or psychologist I can't quite remember at the moment) who has been supportive and respectful of her ME, and who hasn't treated as a psych issue. So they may be like gold dust but it seems they are out there.
@Andy, re Woolie's enquiry. A long shot, but perhaps your friend might recall the name of their psychiatrist/psychologist?
 
Thanks @Hutan, I looked back up-thread to your linked comment. It was really great to read that many psychiatrists here are actually on-board. I'm happy to be wrong with my earlier comment!

I might also comment that my own experience of seeing a psychologist was also very positive. I went early on when things were first bad for two principal reasons. I had an open mind as to cause and was prepared to do anything to aid recovery (won't we all?); and I recognised that there would very likely be a secondary detrimental psychological effect.

I guess the only question then is whether the insurance companies have certain psychiatrists only on their books or whether @Woolie's friend is free to choose any suitably qualified practitioner for a 2nd opinion.
 
Kia ora koutou, I've just had a conversation with a PwME from Christchurch, who has recently been referred to a psychiatrist as part of the requirements for receiving income protection insurance payments.

The psychiatrist diagnosed him with somatic symptom disorder :(. His insurance claim has thus been refused :(.

I think the only way to overturn this (other than through a positive disease diagnosis) would be by getting a second psychiatric opinion. S I was wondering if anyone here knew of an ME-friendly psychiatrist?

I think its unclear whether this person actually meets the DSM-5 criteria for SSD, because they require excessive anxiety and concern about the health issue. So there's a chance tof challenging the diagnosis.

To be honest, I'm not even sure ME-friendly psychiatrists exist. But here's hoping...

PS feel free to pm me if you prefer.
I've PM'd you.
 
Kia ora koutou, I've just had a conversation with a PwME from Christchurch, who has recently been referred to a psychiatrist as part of the requirements for receiving income protection insurance payments.

The psychiatrist diagnosed him with somatic symptom disorder :(. His insurance claim has thus been refused :(.

I think the only way to overturn this (other than through a positive disease diagnosis) would be by getting a second psychiatric opinion. S I was wondering if anyone here knew of an ME-friendly psychiatrist?

I think its unclear whether this person actually meets the DSM-5 criteria for SSD, because they require excessive anxiety and concern about the health issue. So there's a chance tof challenging the diagnosis.

To be honest, I'm not even sure ME-friendly psychiatrists exist. But here's hoping...

PS feel free to pm me if you prefer.

I would encourage the person involved to use the Registered Nurse service available through MECFS Canterbury, to access local advocacy and support with health professionals and insurers.
A self-referral form would need to be completed. Link on this page. https://mecfscanterbury.nz/#/services/individualsupport

The Canterbury District Health Board has very clear clinical guidance for ME/CFS (based on IOM 2015) on their community and hospital Health Pathways platforms, so one would hope that carries some weight within the region.
There is also the recent letter from Prof Tate, that ME/CFS is not a functional disorder. Available to download on https://m.e.awareness.nz/statements-from-academics
 
ME Auckland have announced that Prof Warren Tate will be speaking at their online AGM...

ME/CFS Support (Auckland) are very excited to announce that our guest speaker for our online Annual General Meeting is Professor Warren Tate.
Saturday, 16th October 2021, 1.30 to 3.30 pm. Online via zoom.

Guest Speaker: Professor Warren Tate, University of Otago, Professor of Biochemistry.

Topic: DNA research of ME/CFS patients, Covid Vaccine for ME/CFS, and the benefits of worldwide attention on Long Covid.
Professor Tate will
+ explain the complex physiology that underpins ME/CFS and his research into specific 'biomarker' signatures in our DNA and proteins.
+ inform us about the Pfizer vaccine safety profile, what the general experience has been worldwide for ME/CFS patients, and his views about when it is appropriate, and when it is not.
+ address how benefits may come to our ME/CFS community regarding the worldwide attention of Long Covid.

ME/CFS Support Auckland AGM:
What have we been doing for the ME/CFS community in Auckland? Vote on our annual resolutions.

Q & A: Ask your questions.

Zoom link: https://us02web.zoom.us/j/89026482594 Passcode: AGM2021
 

Attachments

  • 242205770_4280544075377441_8155351527512128319_n.jpg
    242205770_4280544075377441_8155351527512128319_n.jpg
    110.8 KB · Views: 1
1) North & South (Oct edition) has a short article from a historian's point of view. It draws a line from the "sleeping sickness" that followed the Spanish Flu to long Covid. Tapanui Flu (ME) gets a mention as do Prof Tate and Whitney Dafoe. Nothing groundbreaking but if the general reading audience feels shocked by the neglect and stigma sufferers past and present have been subjected to, that would be a good thing. Not online unfortunately, nor on my library's Press Reader app.

2) There's also a good letter to the editor in this week's Listener, in response to a recent article about research into long Covid which briefly mentioned ME (that article was mostly a rehash of another posted previously). Sorry, photo turned out slightly blurry. Would really like to know who wrote that, to find out more, but looks like the person wants to remain anonymous (or maybe needs to, because of the out-of-court settlement).

Listener letter to editor Oct21 (2).jpg
 
M.E. Awareness NZ obtained permission to share the 18 September article in the NZ Listener about Post-Viral Illness.
The Listener is a print only publication, and does not have online content.

BEYOND THE MYTH
As scientists grapple with long Covid, it’s hoped they will uncover more about what causes other post-viral illnesses.

https://m.e.awareness.nz/beyond-the-myth
 
An email from ANZMES (one of NZ's ME/CFS charities). Covid-19 is just now starting to spread around the country. Professor Tate is highly respected in ME/CFS circles here and his views will surely solidify vaccination hesitancy in some people with ME/CFS. I'll post it on Experiences of vaccinations thread, where any comments would be better placed.

ANZMES asks experts for their recommendations on whether people with ME/CFS (pwME/CFS) should get the COVID-19 vaccine or not.

Dr. Ros Vallings, Howick Health & Medical Centre

COVID-19 can be a severe and debilitating disease which can lead to multi-organ damage and death in some people. If someone with ME/CFS catches COVID-19 it is likely to cause a significant exacerbation or relapse of their ME/CFS symptoms, as has been shown in the UK. Yet those experiencing a heightened immune system may be protected against catching viruses – although there is no guarantee. The Pfizer vaccine that is being administered in New Zealand is well studied and exceptionally safe and provides a high degree of protection. However, as with any vaccine some people with ME/CFS have an exacerbation of symptoms which overlap with the commonly reported side effects of the COVID-19 vaccines. A small percentage of people may have a more severe exacerbation of symptoms. I have many of my ME/CFS patients immunised now and not one has had a bad reaction to date. This may be because they used Dr. Nancy Klimas’ antihistamine suggestions which I recommend. I also provide a prescription for prednisone for patients to use if they get sicker, but it is not to be used long-term, and so far only one patient has needed it. For more information please read the recommendations on Dr. Vallings’ website: http://www.drvallings.co.nz/news-items/covid-19-vaccines

Emeritus Professor Warren Tate

I’m a strong advocate for vaccination of any family household member who is not health compromised as this provides protection for the unvaccinated, however I propose a cautious approach for all people with ME/CFS. This is because although the predictive analyses of immunologists might suggest the risk of ongoing relapse (of ME/CFS symptomatology) is small, the patient self-reporting suggests the risk is significant. For example if the person with ME/CFS experiences severe food allergies, chemical hypersensitivities, is prone to frequent debilitating relapses and has a significant compromised level of activity, then I would suspect a much higher risk in comparison to pwME/CFS who do not have these extra dimensions of the illness. In two international studies that came across my desk in regards to the Pfizer vaccine (administered here in NZ) after one dose, 10% reported severe effects on ME/CFS, 40% had mild-moderate effects and 50% had no effects. After the second dose, again 50% had no significant effects, yet nearly 30% had severe effects for at least one month, and 20% had moderate effects. Another study has reported 30% severe effects after the first dose. Anecdotally, of the three women in my university group who had the vaccine, one required hospitalisation for IV fluids after 2 weeks of being severely affected, another had two weeks of a moderate relapse and the third woman had no significant side effects. This seems to mirror the international patient reporting of the much larger groups, and made their results seem genuine to me. I believe therefore that I cannot provide a blanket recommendation for or against the vaccine, but rather believe that each individual should weigh up the decision based on their personal ME/CFS history. If pwME/CFS decide to vaccinate then I would suggest following Dr. Klimas’ antihistamine protocol.

Dr. Nancy Klimas, Nova Southeastern University

COVID kills people. It kills people with over-activated and damaged immune systems preferentially - and that is what ME/CFS is all about. So while there certainly is a risk for an ME relapse with these hyper reactive vaccines, you have to weigh the possibility of an ME relapse against the risk of death from COVID-19. For more information and for advice for people with mast cell activation syndrome visit: https://www.nova.edu/nim/To-Vaccinate-or-Not-with-MECFS.html

In conclusion from our experts

There is not a definitive answer about whether pwME/CFS should or should not get the COVID-19 vaccine. As the condition is highly individualised, so too, is the response to the vaccine. Some have no effects, some only the expected immune response, some experience improvement of symptoms, and some a worsening of symptoms or a relapse. So what is appropriate for the individual is best considered in conjunction with your GP or specialist who has access to your personal medical history.

Should you choose to vaccinate

Center for Disease Control (CDC) states that people with ME/CFS or fibromyalgia should rest for several days before and after the vaccine, as anecdotal information shows that symptoms can resurface while the immune system is activated. The CDC provide information on what to expect before and after your vaccine: https://www.cdc.gov/coronavirus/2019-ncov/vaccines/expect/after.html

Dr. Lucinda Bateman, Bateman Horne Center states that pwME/CFS should be rested and stable prior to the vaccine, and plan on resting/relaxing for at least 72 hours afterward. Supportive care will include anything you usually do for flu symptoms, PEM, allergy flares, worsened orthostatic intolerance, etc. If anything, including a vaccine, makes you sick enough that you are unable to maintain adequate fluids and nutrition, or results in fluid and electrolyte losses (sweating, diarrhea, etc), it is always appropriate to seek IV fluids as a primary intervention.

Antihistamine Usage

Dr. Klimas suggests that before the vaccine, make sure you are taking enough antioxidants, particularly NAC or glutathione and CoQ10. Take an antihistamine before and for several days after the vaccine – the strongest one you can tolerate. Please note: that if you take the vaccine you should take the whole recommended dose, and the current vaccine Pfizer should be administered twice.

As always when dealing with medications and supplements please only do so under the direction of your General Practitioner or Medical Professional to ensure correct dosage administration and to avoid contraindications with your existing medications and personal medical history.

Further discussion of this issue here:
New Zealand: Covid-19 vaccinations for people with ME/CFS
 
Last edited:
NZ Geographic has a lengthy article on long Covid. Nothing new to members here but it's a good piece and ME gets discussed towards the end.
“The thing is, this was completely predictable,” says immunologist Anna Brooks. “And the thing about long COVID is that it’s not a completely new phenomenon. It’s not a mystery disease. It’s none of those things. It’s a post-viral condition.”

Scientists have known for a long time that some people who catch viruses don’t recover—for months, or years, or at all. These conditions have a variety of types and names: myalgic encephalitis (ME), also called chronic fatigue syndrome (CFS), or post-viral syndrome, or sometimes they have no name at all. The lingering illness that struck flu survivors after an outbreak in Tapanui, near Dunedin, in 1982 never got an official title. (There are perhaps 75 outbreaks known to have caused residual long-term illness.)
https://www.nzgeo.com/stories/the-known-unknowns/

ANZMES have put some $$$ towards Anna Brooks' research:
https://anzmes.org.nz/anzmes-sponsors-nz-long-covid-me-research/

But also still fundraising here:
https://www.auckland.ac.nz/en/giving/donate/a-z-list-of-funds/long-covid-research-project.html
 
From the ANZMES website, about the research.
The experience Dr. Brooks refers to is that of Prof. Tate, winner of the Rutherford medal in 2010, who has been investigating ME/CFS since 2012, and has identified molecular signatures of ME/CFS. As co-investigators for this new study, Dr. Brooks and her team are conducting immunological studies and Prof. Tate and his team are performing molecular studies of Long COVID and its relationship to ME/CFS. Prof. Tate aims to perform molecular analyses on a subgroup of this study in addition to providing samples from his ME/CFS patient group for analysis of immunological status before and after vaccination. In addition to being an experienced cellular immunologist, Dr. Brooks is also Director of Auckland Cytometry, the core facility which houses the leading-edge technologies necessary to perform these critical analyses.

How will this research benefit the ME/CFS community? Since a certain percentage of people with Long COVID symptoms also fit the diagnostic criteria for ME/CFS and many go on to receive this diagnosis as well, the samples analysed as part of this study will be beneficial in tracking early onset ME/CFS in comparison to Long COVID. It is hoped that the researchers will be able to identify key markers of immune dysfunction, especially as a percentage of samples will be obtained at very early stages of disease. This investigation into the unique immune signature of ME/CFS and Long COVID has the potential to unveil a biomarker specific to these conditions. As Dr. Brooks’ core expertise is with advanced flow cytometry, this research will screen for over 100 immune cell biomarkers which to date supersedes any previously screened for in ME/CFS research. “This will be a world first.” states Dr. Brooks.

As a side note, I found the explanation of the ANZMES logo on the website, beside the detail about the research, rather sad:
The ANZMES logo, is the New Zealand Albatross. This is symbolic as these birds need a good strong wind to lift them up so that they can fly; rather like the help sufferers need from others in order to begin their lives again.
Of course, there's some truth in that, but it makes it sound as if we are sitting around, without lives, until someone comes along to lift us up, and, when they do, we recover. It patronisingly makes us sound like damsels in distress. It suggests nothing about how it is often possible to live a worthwhile life while waiting for the breakthrough in medical knowledge, nor does it recognise the huge part people with ME/CFS have played in progressing the understanding of the illness and fighting misinformation.

Discussion of the ANZMES albatross logo description continued here
New Zealand: ANZMES
 
Last edited:
Back
Top Bottom